Compound Detail
CHEMBL995
LOSARTAN POTASSIUM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
12
Targets
18
Activities
2
Assay Types
4
PK Parameters
20
Publications
20
Known Names
11
Indications
1
Mechanisms
Molecular Properties
422.9
MW (Da)
4.27
ALogP
6
HBA
2
HBD
92.5
PSA (Ų)
0.44
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1995 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Type-1 angiotensin II receptor antagonist | ANTAGONIST | Type-1 angiotensin II receptor | ✓ | ✓ |
Indications
Hypertension Kidney Diseases Kidney Failure, Chronic Proteinuria Stroke Essential Hypertension Hypertrophy, Left Ventricular Marfan Syndrome Eosinophilic Esophagitis Non-alcoholic Fatty Liver Disease Pre-Eclampsia
Drug Warnings
Black Box Warning
teratogenicity
Activity Summary
IC50 16 meas. best 8.82
Ki 2 meas. best 8.05
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Type-1 angiotensin II receptor B CHEMBL263 | IC50 | 8.82 | 8.415 | 1.5 | 2 |
| Angiotensin II receptor CHEMBL2094256 | IC50 | 8.52 | 8.52 | 3.0 | 1 |
| Type-1 angiotensin II receptor CHEMBL227 | IC50 | 8.26 | 8.26 | 5.5 | 1 |
| Angiotensin II receptor (AT-1) type-1 CHEMBL2094250 | IC50 | 8.09 | 8.09 | 8.2 | 2 |
| Type-1 angiotensin II receptor B CHEMBL263 | Ki | 8.05 | 7.825 | 9.0 | 2 |
| Type-1 angiotensin II receptor CHEMBL1671613 | IC50 | 7.75 | 7.75 | 18.0 | 1 |
| Angiotensin II receptor CHEMBL2094112 | IC50 | 7.72 | 7.72 | 19.0 | 1 |
| Type-1 angiotensin II receptor CHEMBL3374 | IC50 | 6.82 | 6.82 | 150.0 | 1 |
| Bile salt export pump CHEMBL6020 | IC50 | 5.07 | 5.07 | 8530.0 | 1 |
| Type-2 angiotensin II receptor CHEMBL4607 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
| Phosphodiesterase 3 CHEMBL2094125 | IC50 | 4.89 | 4.89 | 13000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.58 | 4.29 | 26000.0 | 2 |
| ATP-binding cassette sub-family C member 4 CHEMBL1743128 | IC50 | 4.47 | 4.47 | 34100.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 1022.62 | ng.hr.mL-1 | Homo sapiens |
| AUC | 1022.62 | ng.hr.mL-1 | Homo sapiens |
| Cmax | 2000.0 | nM | - |
| T1/2 | 1.5 | hr | - |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 1469703 | 10.1021/jm00103a014 | Rattus norvegicus | 9 |
| - | 10.1016/S0960-894X(96)00250-8 | Rattus norvegicus | 8 |
| 23956101 | 10.1093/toxsci/kft176 | Homo sapiens | 8 |
| 12773029 | 10.1021/jm0204237 | ADMET | 5 |
| 8340921 | 10.1021/jm00067a016 | Angiotensin II receptor | 4 |
| 12773029 | 10.1021/jm0204237 | Unchecked | 3 |
| 12773029 | 10.1021/jm0204237 | Type-1 angiotensin II receptor | 2 |
| 17651974 | 10.1016/j.bmc.2007.06.056 | NON-PROTEIN TARGET | 2 |
| - | 10.1016/S0960-894X(00)80076-1 | Rattus norvegicus | 2 |
| 23956101 | 10.1093/toxsci/kft176 | ATP-binding cassette sub-family C member 2 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 1433210 | 10.1021/jm00100a007 | Angiotensin II receptor | 1 |
| - | 10.6019/CHEMBL4513141 | Staphylococcus aureus | 1 |
| 8201597 | 10.1021/jm00037a014 | Angiotensin II receptor (AT-1) type-1 | 1 |
| 8201597 | 10.1021/jm00037a014 | Angiotensin II receptor | 1 |
| 8201597 | 10.1021/jm00037a014 | Type-1 angiotensin II receptor B | 1 |
| 8201597 | 10.1021/jm00037a014 | Unchecked | 1 |
| 1433210 | 10.1021/jm00100a007 | Type-1 angiotensin II receptor | 1 |
| - | 10.1016/0960-894X(95)00477-B | Type-2 angiotensin II receptor | 1 |
| - | 10.1016/0960-894X(95)00477-B | Angiotensin II receptor | 1 |
Data from ChEMBL 36 via Core Engine